Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Growject approved for fourth indication in Japan

Aug. 24, 2012

Sato Pharmaceutical designs new urate anion exchanger inhibitors

Aug. 24, 2012

Investigators extract new HMG-CoA reductase inhibitors from yeast

Aug. 24, 2012

Amgen products target free fatty acid FFA1 receptor for diabetes

Aug. 24, 2012

Centaurus BioPharma divulges novel GPR119 receptor agonist

Aug. 24, 2012

Bristol-Myers Squibb reports discovery and first clinical data for new 11-beta-HSD1 inhibitor

Aug. 23, 2012

Glymera enters phase IIb trial for uncontrolled type 2 diabetes

Aug. 22, 2012

Medivir moves MIV-711 into phase Ib testing

Aug. 22, 2012

Small molecule shows potential for as a contraceptive for men

Aug. 22, 2012

Japanese approval for new dosage of Amaryl

Aug. 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...